Mirum Pharmaceuticals, Inc. MIRM
87.03 USD +1.29 (+1.50%)
At closeNov 3, 2026, 4:42 PM EST
88.22 +1.19 +1.37%
After hours · Nov 3, 4:42 PM ET
85.89 Day range 88.54
63.23 52-week range 130.00
- YTD
- +10.18%
- 1 year
- +22.84%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 153.43 +76.3% upside
Now 87.03
- Target (low)
- 118.00
- Target (mean)
- 153.43
- Target (high)
- 200.00
Ratings (0m) 14 14 buy · 0 hold · 0 sell
- Strong buy4
- Buy10
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 14
- 1 month ago 14
- 2 months ago 14
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.415 | -0.53 – -0.30 | 0.05 | -930.0% | 178.04M | +33.9% | 2 |
| Next quarter | -0.44 | -0.44 – -0.44 | -0.12 | -266.7% | 183.22M | +23.0% | 1 |
| Current year | -15.23 | -15.23 – -15.23 | -0.47 | -3140.4% | 698.11M | +33.9% | 1 |
| Next year | -0.17 | -0.17 – -0.17 | -15.23 | +98.9% | 819.57M | +17.4% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 21, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 15, 2026 | Stifel | Maintained | Buy | Buy |
| Oct 13, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Oct 13, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 12, 2026 | Citigroup | Maintained | Buy | Buy |
| Oct 12, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 8, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Sep 29, 2026 | Citigroup | Maintained | Buy | Buy |
| Sep 29, 2026 | Baird | Maintained | Outperform | Outperform |
| Sep 28, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 27, 2026 | Citizens | Reiterated | Market Outperform | Market Outperform |
| Aug 6, 2026 | TD Cowen | Maintained | Buy | Buy |
| Aug 6, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 6, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Aug 6, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 7, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 2, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jun 15, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Jun 11, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jun 2, 2026 | Citigroup | Initiated | — | Buy |
| May 19, 2026 | Wolfe Research | Initiated | — | Outperform |
| May 7, 2026 | TD Cowen | Maintained | Buy | Buy |
| May 7, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| May 7, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| May 7, 2026 | Baird | Maintained | Outperform | Outperform |
| May 5, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| May 4, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Apr 29, 2026 | Stifel | Maintained | Buy | Buy |
| Apr 28, 2026 | Baird | Maintained | Outperform | Outperform |
| Apr 27, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |